Vahtera E - Search Results

1

Effects of dietary fat modification on fibrinogen, factor VII, and plasminogen activator inhibitor-1 activity in subjects with impaired glucose tolerance.

Niskanen L, Schwab US, Sarkkinen ES, Krusius T, Vahtera E, Uusitupa MI. Niskanen L, et al. Among authors: vahtera e. Metabolism. 1997 Jun;46(6):666-72. doi: 10.1016/s0026-0495(97)90011-1. Metabolism. 1997. PMID: 9186303 Clinical Trial.

2

Weight change and blood coagulability and fibrinolysis in healthy obese women.

Rissanen P, Vahtera E, Krusius T, Uusitupa M, Rissanen A. Rissanen P, et al. Among authors: vahtera e. Int J Obes Relat Metab Disord. 2001 Feb;25(2):212-8. doi: 10.1038/sj.ijo.0801540. Int J Obes Relat Metab Disord. 2001. PMID: 11410822 Clinical Trial.

3

Habitual diet, platelet function, fibrinogen and factor VII coagulant activity in young Finns.

Mutanen M, Krusius T, Räsänen L, Freese R, Vahtera E, Viikari JS. Mutanen M, et al. Among authors: vahtera e. J Intern Med. 1995 Jun;237(6):577-83. doi: 10.1111/j.1365-2796.1995.tb00888.x. J Intern Med. 1995. PMID: 7782730

4

Utility of the Arg/Gln polymorphism of the factor VII (FVII) gene, serum lipid levels and body mass index in the prediction of the FVII:C and FVII:Ag in North Karelia; a cross-sectional and prospective study.

Stengård JH, Salomaa V, Rasi V, Vahtera E, Ehnholm C, Krusius T, Perola M, Vartiainen E. Stengård JH, et al. Among authors: vahtera e. Blood Coagul Fibrinolysis. 2001 Sep;12(6):445-52. doi: 10.1097/00001721-200109000-00004. Blood Coagul Fibrinolysis. 2001. PMID: 11555697

5

Short-term aspirin treatment does not reduce plasma fibrinogen concentration in young healthy adults.

Krusius T, Hirvonen M, Vahtera E, Kala R. Krusius T, et al. Among authors: vahtera e. Thromb Res. 1994 Sep 15;75(6):653-6. doi: 10.1016/0049-3848(94)90177-5. Thromb Res. 1994. PMID: 7831684 Clinical Trial. No abstract available.

6

An unfavorable combination of Factor V Leiden with age, weight, and blood group causes high risk of pregnancy-associated venous thrombosis: a population-based nested case-control study.

Hiltunen L, Rautanen A, Rasi V, Kaaja R, Kere J, Krusius T, Vahtera E, Paunio M. Hiltunen L, et al. Among authors: vahtera e. Thromb Res. 2007;119(4):423-32. doi: 10.1016/j.thromres.2006.04.001. Epub 2006 Jun 12. Thromb Res. 2007. PMID: 16765424

7

[APC resistance and blood coagulation factor V mutation in Finnish thrombotic patients].

Hakala L, Vahtera E, Krusius T, Rasi V. Hakala L, et al. Among authors: vahtera e. Duodecim. 1995;111(22):2143-51. Duodecim. 1995. PMID: 9841174 Clinical Trial. Finnish. No abstract available.

8

Genetic background of type I protein C deficiency in Finland.

Kuismanen K, Levo A, Vahtera E, Rasi V, Labrouche S, Freyburger G, Krusius T, Partanen J. Kuismanen K, et al. Among authors: vahtera e. Thromb Res. 2006;118(5):603-9. doi: 10.1016/j.thromres.2005.10.009. Epub 2005 Dec 19. Thromb Res. 2006. PMID: 16360797

9

The effects of saturated fat and n-6 polyunsaturated fat on postprandial lipemia and hemostatic activity.

Salomaa V, Rasi V, Pekkanen J, Jauhiainen M, Vahtera E, Pietinen P, Korhonen H, Kuulasmaa K, Ehnholm C. Salomaa V, et al. Among authors: vahtera e. Atherosclerosis. 1993 Oct;103(1):1-11. doi: 10.1016/0021-9150(93)90034-r. Atherosclerosis. 1993. PMID: 8280180

10

Fibrinolytic defect in chronic back pain. A controlled study of plasminogen activator activity in 20 patients.

Hurri HO, Petäjä JM, Alaranta HT, Landtman MC, Soini JR, Vahtera EM, Laitinen HI. Hurri HO, et al. Among authors: vahtera em. Acta Orthop Scand. 1991 Oct;62(5):407-9. doi: 10.3109/17453679108996633. Acta Orthop Scand. 1991. PMID: 1835242

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

69 results

Search Page

Filters